| | | |

National Nutrition Month: The Role of Food in Mesothelioma Survival

Given the aggressive and treatment-resistant nature of malignant mesothelioma, it can be frustrating for patients to hear news about experimental therapies that may be decades away from clinical use.

But patients are far from powerless, as the stories of mesothelioma survivors like Paul Kraus prove. At 20+ years post-diagnosis, Kraus is the longest-living mesothelioma survivor in the world and credits his longevity, in large measure, to dietary and lifestyle changes.

During this year’s National Nutrition Month, the Academy of Nutrition and DIetetics is reminding everyone of the power of nutrition to impact health and wellbeing. This year’s theme, “Go Further with Food”, is a fitting slogan for mesothelioma patients and those with other cancers.

Nutrition and Malignant Mesothelioma

Malignant mesothelioma is usually caused by asbestos exposure. When asbestos enters the body, it embeds itself in the tissues, triggering a cascade of cellular changes that can result in peritoneal or pleural mesothelioma decades later.

But evidence suggests that certain foods may be able to help counter those effects. A report published last year in the journal Biomedicine and Pharmacotherapy suggests that dietary phytochemicals impact the expression of microRNA, a small non-coding RNA molecule that plays a role in how genes are expressed.

One compound in particular – ursolic acid found in apple peels – has been shown to regulate microRNAs in malignant mesothelioma cells. But many others, including dietary phytochemicals found in fruits and vegetables, mushrooms, wine, herbs, and spices may also be powerful weapons in the fight against mesothelioma.

 

Since 2016, new studies have been released on

  • The potential mesothelioma survival benefits of the flavonoid apigenin found in parsley and chamomile tea
  • The apparent ability of the broccoli compound sulforaphane to improve mesothelioma chemotherapy with cisplatin
  • The immune-boosting properties of micronutrients in red wine, tea, and leafy greens in people with mesothelioma
  • The mesothelioma tumor growth-slowing effect of the polyphenol curcumin

Eating During Mesothelioma Treatment and Beyond

According to the National Comprehensive Cancer Network, patients undergoing treatment for mesothelioma and other cancers should aim to eat a minimum of five servings of fruit and vegetables daily along with whole grains, lean protein, and lowfat dairy.

They recommend that patients aim for a “balanced plate” that includes one fourth lean protein, one half cooked or raw vegetables, and one fourth whole grains.  There is some evidence that eating foods rich in vitamin D may decrease the risk of recurrent mesothelioma and improve survival. Alcohol has been linked to cancer risk and should be minimized.

Not only can nutrient-dense food help repair tissue damage caused by mesothelioma treatment, but it can also help counter treatment-related side effects.

Avoiding fried, sugary or spicy foods can help counter nausea and vomiting that can accompany chemotherapy and consuming more water helps fight dry mouth and dehydration.

Because decreased appetite and weight loss are common for mesothelioma patients during treatment, your doctor may recommend frequent smaller meals and nutritional drinks as a way to consume more calories and maintain energy.

Sources:

“Nutrition for Cancer Survivors”, National Comprehensive Cancer Network, Accessed March 27, 2918

Academy of Nutrition and Dietetics, National Nutrition Month page

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…